Save information for later
Sign Up

Learn About Chronic B-Cell Leukemia (CBCL)

View Main Condition: Leukemia

What is the definition of Chronic B-Cell Leukemia (CBCL)?
Chronic B cell leukemia is a type of chronic lymphocytic leukemia (CLL), or cancer of the blood and bone marrow that mainly affects adults. In chronic B cell leukemia, the bone marrow produces too many B lymphocytes, which are white blood cells that fight infection. Chronic B cell leukemia represents 95% of all chronic lymphocytic leukemias.
What are the symptoms of Chronic B-Cell Leukemia (CBCL)?
Individuals with early chronic B cell leukemia may not have any symptoms. Symptoms of intermediate and advanced stage chronic B cell leukemia may include painless, enlarged lymph nodes; fatigue; fever; pain in the upper left region of the abdomen; enlarged spleen; easy bruising or bleeding; pinpoint, dark red spots under the skin (petechiae); night sweats; weight loss; and frequent infections.
Not sure about your diagnosis?
Check Your Symptoms
What are the current treatments for Chronic B-Cell Leukemia (CBCL)?
Treatment for chronic B cell leukemia depends on the stage. Early stage chronic B cell leukemia may not need treatment and may involve watchful waiting. Treatment for intermediate and advanced stages chronic B cell leukemia may include targeted therapy, chemotherapy, radiation therapy, immunotherapy, and bone marrow or peripheral stem cell transplant.
Who are the top Chronic B-Cell Leukemia (CBCL) Local Doctors?
Advanced in Chronic B-Cell Leukemia (CBCL)
Hematology Oncology | Hematology | Oncology
Advanced in Chronic B-Cell Leukemia (CBCL)
Hematology Oncology | Hematology | Oncology

Phc-Las Cruces Inc

2450 S Telshor Blvd, 
Las Cruces, NM 
 (2.5 mi)
Languages Spoken:
English

William Adler is a Hematologist Oncology specialist and a Hematologist in Las Cruces, New Mexico. Dr. Adler and is rated as an Advanced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Dyserythropoietic Anemia and Thrombocytopenia, Paget Disease of the Breast, Breast Cancer, and Familial Colorectal Cancer.

Experienced in Chronic B-Cell Leukemia (CBCL)
Oncology | Hematology
Experienced in Chronic B-Cell Leukemia (CBCL)
Oncology | Hematology
2801 Missouri Ave, Suite 27, 
Las Cruces, NM 
 (2.0 mi)
Languages Spoken:
English

Constance Wash is an Oncologist and a Hematologist in Las Cruces, New Mexico. Dr. Wash and is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). Her top areas of expertise are Breast Cancer, Paget Disease of the Breast, Non-Hodgkin Lymphoma, and Familial Pancreatic Cancer.

 
 
 
 
Learn about our expert tiers
Learn More
Experienced in Chronic B-Cell Leukemia (CBCL)
Hematology Oncology
Experienced in Chronic B-Cell Leukemia (CBCL)
Hematology Oncology
4351 E Lohman Ave, Ste 209, 
Las Cruces, NM 
 (2.1 mi)
Languages Spoken:
English

Bishnu Rauth is a Hematologist Oncology provider in Las Cruces, New Mexico. Dr. Rauth and is rated as an Experienced provider by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Non-Hodgkin Lymphoma, Gastric Lymphoma, Inflammatory Breast Cancer, Sideroblastic Anemia, and Bone Marrow Aspiration.

What are the latest Chronic B-Cell Leukemia (CBCL) Clinical Trials?
Correlative Study of Epcoritamab in Chronic Lymphocytic Leukemia and Richter Syndrome

Summary: This correlative study aims to understand the pharmacodynamic effects and clonal dynamics in response to epcoritamab by obtaining and analyzing lymph node, bone marrow, and blood samples from subjects enrolled in GCT3013-03 trial sponsored by Genmab at NIH. Samples will be collected before and at multiple time points during treatment with epcoritamab. National Heart, Lung, and Blood Institute (NHL...

Match to trials
Find the right clinical trials for you in under a minute
Get started
Randomized Phase 2 Study Comparing Acalabrutinib to Acalabrutinib and Obinutuzumab in the Treatment of Patients With Early-Stage Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL) Who Are at High Risk of Disease Progression

Summary: This phase II trials studies how well acalabrutinib with or without obinutuzumab works in treating patients with early-stage chronic lymphocytic leukemia or small lymphocytic lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Immunotherapy with monoclonal antibodies, such as obinutuzumab, may help the body's immune system attack the ...